184 related articles for article (PubMed ID: 31010936)
1. Duration of Dual Antiplatelet Therapy in Patients with CKD and Drug-Eluting Stents: A Meta-Analysis.
Mavrakanas TA; Chatzizisis YS; Gariani K; Kereiakes DJ; Gargiulo G; Helft G; Gilard M; Feres F; Costa RA; Morice MC; Georges JL; Valgimigli M; Bhatt DL; Mauri L; Charytan DM
Clin J Am Soc Nephrol; 2019 Jun; 14(6):810-822. PubMed ID: 31010936
[TBL] [Abstract][Full Text] [Related]
2. Mortality in patients treated with extended duration dual antiplatelet therapy after drug-eluting stent implantation: a pairwise and Bayesian network meta-analysis of randomised trials.
Palmerini T; Benedetto U; Bacchi-Reggiani L; Della Riva D; Biondi-Zoccai G; Feres F; Abizaid A; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Genereux P; Bhatt DL; Orlandi C; De Servi S; Petrou M; Rapezzi C; Stone GW
Lancet; 2015 Jun; 385(9985):2371-82. PubMed ID: 25777667
[TBL] [Abstract][Full Text] [Related]
3. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Bittl JA; Baber U; Bradley SM; Wijeysundera DN
J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
[TBL] [Abstract][Full Text] [Related]
4. Duration of dual antiplatelet therapy following drug-eluting stent implantation: A systemic review and meta-analysis of randomized controlled trials with longer follow up.
Sharma A; Agrawal S; Garg A; Vallakati A; Lavie CJ; Helft G
Catheter Cardiovasc Interv; 2017 Jul; 90(1):31-37. PubMed ID: 28557264
[TBL] [Abstract][Full Text] [Related]
5. Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials.
Abo-Salem E; Alsidawi S; Jamali H; Effat M; Helmy T
Cardiovasc Ther; 2015 Oct; 33(5):253-63. PubMed ID: 26010419
[TBL] [Abstract][Full Text] [Related]
6. Dual Antiplatelet Therapy Continuation Beyond 1 Year After Drug-Eluting Stents: A Meta-Analysis of Randomized Trials.
Ferrante G; Condorelli G; Pagnotta P; Reimers B
Circ Cardiovasc Interv; 2017 May; 10(5):. PubMed ID: 28500135
[TBL] [Abstract][Full Text] [Related]
7. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
[TBL] [Abstract][Full Text] [Related]
8. Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials.
Ziada KM; Abdel-Latif AK; Charnigo R; Moliterno DJ
Catheter Cardiovasc Interv; 2016 Mar; 87(4):722-732. PubMed ID: 26309050
[TBL] [Abstract][Full Text] [Related]
9. Optimal Duration of Dual Antiplatelet Therapy After DES Implantation: A Meta-Analysis of 11 Randomized Trials.
Verdoia M; Schaffer A; Barbieri L; Montalescot G; Collet JP; Colombo A; Suryapranata H; De Luca G
Angiology; 2016 Mar; 67(3):224-38. PubMed ID: 26069031
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of the Duration of Dual Antiplatelet Therapy in Patients Treated With Second-Generation Drug-Eluting Stents.
D'Ascenzo F; Moretti C; Bianco M; Bernardi A; Taha S; Cerrato E; Omedè P; Montefusco A; Frangieh AH; Lee CW; Campo G; Chieffo A; Quadri G; Pavani M; Zoccai GB; Gaita F; Park SJ; Colombo A; Templin C; Lüscher TF; Stone GW
Am J Cardiol; 2016 Jun; 117(11):1714-23. PubMed ID: 27134057
[TBL] [Abstract][Full Text] [Related]
11. Dual Antiplatelet Therapy After Drug-Eluting Stents Implantation in East Asians: A Network Meta-Analysis of Randomized Controlled Trials.
Zhong PY; Shang YS; Bai N; Ma Y; Niu Y; Wang ZL
J Cardiovasc Pharmacol; 2022 Aug; 80(2):216-225. PubMed ID: 35561287
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of dual antiplatelet therapy after coronary stenting in patients with chronic kidney disease.
Hwang D; Park KW; Lee JM; Rhee TM; Hong MK; Jang Y; Valgimigli M; Colombo A; Gilard M; Palmerini T; Stone GW; Kim HS
Am Heart J; 2018 Mar; 197():103-112. PubMed ID: 29447770
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of ≤6-month versus 12-month dual antiplatelet therapy after drug-eluting stent implantation: A meta-analysis and meta-regression.
Villablanca PA; Massera D; Mathew V; Bangalore S; Christia P; Perez I; Wan N; Schulz-Schüpke S; Briceno DF; Bortnick AE; Garcia MJ; Lucariello R; Menegus M; Pyo R; Wiley J; Ramakrishna H
Medicine (Baltimore); 2016 Dec; 95(52):e5819. PubMed ID: 28033306
[TBL] [Abstract][Full Text] [Related]
14. Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.
Palmerini T; Della Riva D; Benedetto U; Bacchi Reggiani L; Feres F; Abizaid A; Gilard M; Morice MC; Valgimigli M; Hong MK; Kim BK; Jang Y; Kim HS; Park KW; Colombo A; Chieffo A; Sangiorgi D; Biondi-Zoccai G; Généreux P; Angelini GD; Pufulete M; White J; Bhatt DL; Stone GW
Eur Heart J; 2017 Apr; 38(14):1034-1043. PubMed ID: 28110296
[TBL] [Abstract][Full Text] [Related]
15. Short-Term Versus Long-Term Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation in Elderly Patients: A Meta-Analysis of Individual Participant Data From 6 Randomized Trials.
Lee SY; Hong MK; Palmerini T; Kim HS; Valgimigli M; Feres F; Colombo A; Gilard M; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Stone GW
JACC Cardiovasc Interv; 2018 Mar; 11(5):435-443. PubMed ID: 29454730
[TBL] [Abstract][Full Text] [Related]
16. Association Between Duration of Dual Antiplatelet Therapy and Angiographic Multivessel Disease on Outcomes in Patients Treated With Newer-Generation Drug-Eluting Stents.
Lee SY; Hong MK; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Kim HS; Valgimigli M; Colombo A; Gilard M; Palmerini T; Stone GW
Circ Cardiovasc Interv; 2016 Nov; 9(11):. PubMed ID: 27803041
[TBL] [Abstract][Full Text] [Related]
17. Risk-Benefit Profile of Longer-Than-1-Year Dual-Antiplatelet Therapy Duration After Drug-Eluting Stent Implantation in Relation to Clinical Presentation.
Palmerini T; Bruno AG; Gilard M; Morice MC; Valgimigli M; Montalescot G; Collet JP; Della Riva D; Bacchi-Reggiani ML; Steg PG; Diallo A; Vicaut E; Helft G; Nakamura M; Généreux P; Vahl TP; Stone GW
Circ Cardiovasc Interv; 2019 Mar; 12(3):e007541. PubMed ID: 30871353
[TBL] [Abstract][Full Text] [Related]
18. Benefits of short-term or prolonged as compared to standard 1 year DAPT in patients with acute coronary syndrome treated with drug-eluting stents: a meta-analysis of 9 randomized trials.
Verdoia M; Kedhi E; Suryapranata H; Frati G; Biondi-Zoccai G; De Luca G
J Thromb Thrombolysis; 2020 Aug; 50(2):337-354. PubMed ID: 31919736
[TBL] [Abstract][Full Text] [Related]
19. The optimal discontinuation of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention with drug-eluting stents: A meta-analysis of randomized trials.
Wang W; Liu J; Fang J; Liu Y; An T; Zou M; Cheng G
Int J Cardiol; 2017 May; 235():73-86. PubMed ID: 28284499
[TBL] [Abstract][Full Text] [Related]
20. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
Pandit A; Giri S; Hakim FA; Fortuin FD
Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
